Mebendazole clinical trial

Apr 26, 2021 · Published: 26 April 2021 A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer S. Apr 26, 2021 · Patients with treatment refractory gastrointestinal cancer were treated with individualized dose adjusted mebendazole up to 4 g/day to target a serum concentration of 300 ng/ml

2024-03-28
    Simvastatin inhibits
  1. Last Updated: 2023-09-13
  2. 10
  3. ANTI-CANCER EFFECTS OF ANTHELMINTICS